INTELLIGENCE IN ACTION

HIMSS18 Panel Gets Candid About Prescription Price Transparency

March 22, 2018

In advance of its highly anticipated conference—widely regarded as the world’s largest health information tradeshow—HIMSS posed this question on its homepage: “Are you ready for the next step in health?” Based on the enthusiasm of the more than 40,000 people who traveled to Las Vegas for this year’s show, the answer was a resounding “yes!”

That same excitement and passion for innovation was evident in the panel discussion we hosted in our booth: Bringing Prescription Price Transparency to the Point of Care. Pat Salber from The Doctor Weighs In moderated a lively discussion that included Casey Leonetti of CVS Health, Dr. Lynne Nowak of Express Scripts, Neil Simon of Aprima Medical Software and our very own Tom Skelton.

Our esteemed panelists explored a number of key challenges and opportunities related to prescription price transparency. According to Dr. Nowak, “[Physicians] care about the patient sitting in front of them and whether that patient can afford the medication or whether that patient is getting the best price within their benefits. So giving visibility … not only to the cost of the medication that is the initial choice, but [also to] those therapeutic alternatives is critical.”

In November 2017, Surescripts announced plans to revolutionize the prescription decision-making process with its Real-Time Prescription Benefit and expanded Prior Authorization solutions. Surescripts has joined forces with six electronic health records (EHR) companies, including Allscripts, Aprima, Cerner, Epic and GE Healthcare, and is leveraging information from pharmacy benefit managers (PBMs) CVS Health and Express Scripts to deliver patient-specific benefit and price information to providers in real time at the point of care.

Watch the panel discussion to learn how delivering patient-specific drug benefit and cost information to the point of care is revolutionizing a critical step in the e-prescribing process—all while improving medication adherence, patient care and costs. Then, take a peek at our Real-Time Prescription Benefit webpage. It’s indeed time to take the next step in health.

Related Articles

March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show demonstrating this impact through the lens of a very hot topic: prescription price transparency.

Read more...
February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Prescription drug prices continue to rise, with no end in sight. Americans have complained to their representatives about the rising prices and policymakers are listening. A new Politico-Harvard poll of U.S. adults found that 80 percent of those surveyed said that lowering prescription drug prices should be an “extremely important” priority for the new Congress. Read more...
February 13, 2019

Prescribers and Patients are Working Together to Save Time, Money and Hassle

Prescription drugs comprise 17 percent of America's prescription drug spending, which is projected to grow by an average of 6.3 percent annually between 2017 and 2026. In fact, just one year from now, we are projected to spend $610-640B on medications alone. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX